🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,39 USD

Máx. histórico

119,27

4269 días

Caída desde máximo

-69,49%

Rango 52 semanas

18,80 – 36,67

Variación hoy

-0,03%

Cierre anterior

36,40

Rango de hoy

36,39 – 36,41

Volumen hoy

1.075.323

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
103,97 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 5 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/11/2012 15,29 15,59 15,18 15,55 +1,83% 2,68% 287.600
15/11/2012 16,20 16,26 15,21 15,27 -5,51% 6,48% 391.400
14/11/2012 16,50 16,57 16,08 16,16 -0,55% 2,97% 396.900
13/11/2012 15,90 16,35 15,89 16,25 +2,20% 2,89% 293.800
12/11/2012 15,68 15,96 15,62 15,90 +1,53% 2,17% 409.900
09/11/2012 15,26 15,90 15,15 15,66 +1,95% 4,91% 223.300
08/11/2012 15,26 15,47 15,14 15,36 +0,26% 2,16% 364.500
07/11/2012 15,52 15,65 15,22 15,32 -2,61% 2,77% 263.000
06/11/2012 15,72 15,95 15,62 15,73 +0,13% 2,10% 263.800
05/11/2012 15,55 15,80 15,07 15,71 -0,32% 4,69% 432.700
02/11/2012 15,99 15,99 15,33 15,76 -0,76% 4,13% 363.300
01/11/2012 16,16 16,49 15,67 15,88 +0,95% 5,07% 576.000
31/10/2012 15,65 15,92 15,13 15,73 +0,64% 5,05% 311.900
26/10/2012 16,07 16,22 15,62 15,63 -2,43% 3,73% 85.300
25/10/2012 16,25 16,38 15,83 16,02 -1,11% 3,38% 249.600
24/10/2012 16,35 17,09 15,98 16,20 -0,18% 6,79% 498.700
23/10/2012 16,04 16,29 15,55 16,23 +1,18% 4,61% 204.900
22/10/2012 16,50 16,50 15,79 16,04 -1,60% 4,30% 192.800
19/10/2012 16,90 16,99 16,07 16,30 -3,44% 5,44% 338.900
18/10/2012 17,90 17,90 16,68 16,88 -5,91% 6,82% 555.400
17/10/2012 17,86 18,52 17,71 17,94 +0,22% 4,54% 236.500
16/10/2012 17,95 18,05 17,59 17,90 -0,50% 2,56% 377.700
15/10/2012 18,04 18,07 17,81 17,99 +0,22% 1,44% 231.700
12/10/2012 17,70 18,09 17,55 17,95 +1,58% 3,05% 122.700
11/10/2012 17,82 17,94 17,59 17,67 -0,06% 1,96% 118.600
10/10/2012 18,10 18,10 17,50 17,68 -2,05% 3,31% 179.300
09/10/2012 18,46 18,50 17,99 18,05 -1,85% 2,76% 226.400
08/10/2012 18,58 18,59 18,10 18,39 -0,86% 2,64% 133.700
05/10/2012 18,70 18,86 18,37 18,55 -0,75% 2,62% 180.000
04/10/2012 18,80 19,09 18,20 18,69 -0,11% 4,73% 390.600